Chen, Z., Shi, M., Peng, L., Wei, W., Li, X., Guo, Z., . . . Guo, R. (2012). Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis. BioMed Central.
Chicago-стиль цитированияChen, Zhi-Yuan, et al. Dovitinib Preferentially Targets Endothelial Cells Rather Than Cancer Cells for the Inhibition of Hepatocellular Carcinoma Growth and Metastasis. BioMed Central, 2012.
MLA-цитированиеChen, Zhi-Yuan, et al. Dovitinib Preferentially Targets Endothelial Cells Rather Than Cancer Cells for the Inhibition of Hepatocellular Carcinoma Growth and Metastasis. BioMed Central, 2012.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.